Merck has agreed to settle pending Vioxx claims for a total of $4.85 billion.
The settlement is an offer of settlement to individual plaintiffs, provided they can show “1) objective medical proof of either a heart attack or ischemic stroke; (2) documented receipt of at least 30 Vioxx pills; and (3) receipt of pills in sufficient number and proximity to the event to support a presumption that the patient was still taking the pills within 14 days before the heart attack or stroke.”
If 85% of the plaintiffs in each of the strongest categories do not accept the settlement, then the offer is void.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.